Serum Osteoprotegerin Level Is Negatively Associated with Bone Mineral Density in Patients Undergoing Maintenance Hemodialysis

Serum Osteoprotegerin Level Is Negatively Associated with Bone Mineral Density in Patients Undergoing Maintenance Hemodialysis

Background and Objectives: Osteoprotegerin (OPG), a potent osteoclast activation inhibitor, decreases bone resorption and plays a role in mediating bone mineral density (BMD). Our aim was to evaluate the relationship between BMD and serum OPG in maintenance hemodialysis (MHD) patients. Materials and...

Full description

Bibliographic Details
Main Authors: Chia-Wen Lu, Chih-Hsien Wang, Bang-Gee Hsu, Jen-Pi Tsai
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Medicina
Subjects:
bone mineral density
hemodialysis
osteoprotegerin
osteopenia
osteoporosis
Online Access:https://www.mdpi.com/1648-9144/57/8/762

Similar Items

Similar Items